Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Rapid Free Communications

GH & IGFs

Abstract unavailable
hrp0089rfc4.7
A Deletion Encompassing Exon 2 of the ALS Gene: Analysis of a Patient with ALS Deficiency and His Family
aEndocrinology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; bServicio de Pediatria, Hospital Higueras, Talcahuano, Chile; cEndocrinology Unit, Pediatrics Division, Pontificia Universidad Catolica de Chile, Santiago, Chile; dFacultad de Medicina, Genetics and Genomics Center, Universidad del Desarrollo y Clínica Alemana, Santiago, Chile; eEndocrinology Department, Pontificia Universidad Católica de Chile, Santiago, Chile
hrp0089rfc4.3
A Longitudinal Study on miRNAs Circulating Levels in a Cohort of SGA and AGA Subjects, Evaluated During Childhood and Young Adulthood
aD.P.U.O. ‘Bambino Gesù’ Children’s Hospital, Rome, Italy; bTor vergata University, Rome, Italy; cDepartment of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden; dKarolinska Institutet and Department of Radiology, Karolinska University Hospital, Stockholm, Sweden; eWomen’s and Children’s Health, Karolinska Institutet, and Neonatology Department, Astrid Lindgren Children’s Hospital, Stockholm, Sweden; fDepartment of Endocrinology, Metabolism and Diabetes, Departments of Medicine and Molecular Medicine and Surgery, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden; gDepartment of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden
hrp0089rfc4.4
12-Month Effects of Once-Weekly and Twice-Monthly Administration of Hybrid Fc-Fused Human Growth Hormone, GX-H9, Treatment in Pediatric with GHD Deficiency
aBashkir State Medical University, Ufa, Russian Federation; bOdessa National Medical University, Odessa, Ukraine; cUkrainian Scientifically Practical Center of Endocrine Surgery and Transplantation of Endocrine Organs and Tissues, Kyev, Ukraine; dInstitute of Endocrinology and Metabolism Named after Komisarenko NAMS of Ukraine, Kyev, Ukraine; eKharkiv National Medical University, Kharkiv, Ukraine; fMarkusovszky University Hospital, Szombathely, Hungary; gSt. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation; hInstitute of Pediatric Endocrinology, Moscow, Russian Federation; iRegional Clinical Children’s Hospital, Ivano-Frankivsk, Ukraine; jBukoinian State Medical University, Chernivtsi, Ukraine; kKangdong Sacred Heart Hospital, Seoul, Republic of Korea; lInha University Hospital, Incheon, Republic of Korea; mSt. John’s Hopital and United Hospitals of Northern Buda, Budapest, Hungary; nAjou University School of Medicine, Ajou University Hospital, Suwon, Republic of Korea; oHANDOK, Inc., Seoul, Republic of Korea; pGenexine, Inc., Seongnam, Republic of Korea.
hrp0089rfc4.5
Effect of 2 Years of Growth Hormone Treatment on Glucose Tolerance in Adults with Prader-Willi Syndrome
aDutch Growth Research Foundation, Rotterdam, Netherlands; bErasmus Medical Center, Rotterdam, Netherlands
hrp0089rfc4.6